Paratyphoid fever: Splicing the global analyses

International Journal of Medical Sciences

Volumn 11, Issue 7, 2014, Pages 732-741

  Teh, Cindy Shuan Ju ^a   Chua, Kek Heng ^a   Thong, Kwai Lin ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Antibiotic resistance; Diagnosis; Epidemiology; Paratyphoid fever; Salmonella Paratyphi A; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ASIA; AUSTRALIA; BACTERIAL GENOME; BACTERIAL TRANSMISSION; BACTERIOLOGY; BACTERIUM CULTURE; BACTERIUM DETECTION; CLINICAL FEATURE; DISEASE CARRIER; DISEASE SURVEILLANCE; EAST ASIA; EUROPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION CONTROL; INFECTION RISK; MOLECULAR DIAGNOSIS; NONHUMAN; PARATYPHOID FEVER; POLYMERASE CHAIN REACTION; REVIEW; SALMONELLA PARATYPHI; SERODIAGNOSIS; SOUTH ASIA; SOUTHEAST ASIA; VACCINATION; CHINA; COMMUNICABLE DISEASES; INDIA; MICROBIOLOGY; NEPAL; PAKISTAN; PATHOGENICITY; PATHOLOGY; PUBLIC HEALTH; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR PARATYPHI A;

CHINA; COMMUNICABLE DISEASES; HUMANS; INDIA; NEPAL; PAKISTAN; PARATYPHOID FEVER; PUBLIC HEALTH; SALMONELLA PARATYPHI A;

EID: 84900435480     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.7768     Document Type: Review

References (105)

1. Fangtham M, Wilde H. Emergence of Salmonella Paratyphi A as a major cause of enteric fever: Need for early detection, preventive measures, and effective vaccines. J Travel Med. 2008; 15: 344-350. doi: 10.1111/j.1708-8305.2008.00237.x.
2. Health Protection Agency. Investigation of Faecal Specimens for Enteric Pathogens. UK Standards for Microbiology Investigations. 2013; 8(B):30.
3. Ochiai RL, Wang XY, von Seidlein L, Yang J, Bhutta ZA, Bhattacharya SK, et al. Salmonella paratyphi A rates, Asia. Emerg Infect Dis. 2005; 11: 1764-1766.
4. Girard MP, Steele D, Chaignat CL, Kieny MP. A review of vaccine research and development: human enteric infections. Vaccine. 2006; 24: 2732-2750. doi: 10.1016/j.vaccine.2005.10.014.
5. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. B World Health Organ. 2004; 82: 346-353.
6. Connor BA, Schwartz E. Typhoid and paratyphoid fever in travellers. The Lancet infectious diseases. 2005; 5: 623-628. doi:10.1016/S1473-3099(05)70239-5.
7. Wilson GS, Miles AA. Principles of Bacteriology and Immunity; Fifth Edition (Vol 1). Great Britain: Edward Arnold (Publishing) Ltd; 1964.
8. Thomas HL, Addiman S, Mellanby A. Evaluation of the effectiveness and efficiency of the public health management of cases of infection due to Salmonella typhi/paratyphi in North East London. Public health. 2006; 120: 1188-1193. doi:10.1016/j.puhe.2006.06.013.
9. Vollaard AM, Ali S, Widjaja S, Asten HA, Visser LG, Surjadi C, et al. Identification of typhoid fever and paratyphoid fever cases at presentation in outpatient clinics in Jakarta, Indonesia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2005; 99: 440-450. doi:10.1016/j.trstmh.2004.09.012.
10. Riyaz-Ul-Hassan S, Verma V, Qazi GN. Rapid detection of Salmonella by polymerase chain reaction. Molecular and cellular probes. 2004; 18: 333-339. doi:10.1016/j.mcp.2004.05.003.
11. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever. The New England journal of medicine. 2002; 347: 1770-1782. doi:10.1056/NEJMra020201.
12. Gal-Mor O, Suez J, Elhadad D, Porwollik S, Leshem E, Valinsky L, et al. Molecular and cellular characterization of a Salmonella enterica serovar Paratyphi a outbreak strain and the human immune response to infection. Clinical and vaccine immunology: CVI. 2012; 19: 146-156. doi:10.1128/CVI.05468-11.
13. Lolekha S. Salmonella carrier: its evolution and treatment. Sotheast Asian J Trop Med Publ Health. 1995; 26: 77-79.
14. Pegues DA, Michael EO and Miller SI. Salmonella, Including Salmonella Typhi. In Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, ed. Infections of the Gastrointestinal Tract. Philadelphia: Lippincott Williams and Wilkins; 2002: 667-669.
15. Stock I, Wiedemann B. Natural antibiotic susceptibility of Salmonella enterica strains. Int J Antimicrob Ag. 2000; 16: 211-217. doi: 10.1016/S0924-8579(00)00204-1.
16. Edwards PR, Ewing WH. Identification of Enterobacteriaceae; Third Edition. Atlanta, Georgia: Burgess Publishing Company; 1972.
17. McClelland M, Sanderson KE, Clifton SW, Latreille P, Porwollik S, Sabo A, et al. Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid. Nat Genet. 2004; 36: 1268-1274. doi: 10.1038/Ng1470.
18. Didelot X, Bowden R, Street T, Golubchik T, Spencer C, McVean G, et al. Recombination and Population Structure in Salmonella enterica. Plos Genet. 2011; 7. doi: 10.1371/journal.pgen.1002191.
19. Holt KE, Thomson NR, Wain J, Phan MD, Nair S, Hasan R, et al. Multi-drug-resistant Salmonella enterica serovar Paratyphi A harbors IncHI1 plasmids similar to those found in serovar Typhi. J Bacteriol. 2007; 189: 4257-4264. doi: 10.1128/Jb.00232-07.
20. Mandal S, Mandal MD, Pal NK. Antibiotic resistance of Salmonella enterica serovar Paratyphi A in India: emerging and reemerging problem. Journal of postgraduate medicine. 2006; 52: 163-166.
21. Panigrahi D, Chugh TD, West PWJ, Dimitrov TZ, Groover S, Mehta G. Antimicrobial susceptibility, phage typing and plasmid profile of Salmonella enter-ica serotype paratyphi a strains isolated in Kuwait. Med Prin Pract. 2003; 12: 252-255. doi: 10.1159/000072293.
22. Huang H, Li J, Yang XL, Wang YG, Wang YP, Tao JS, et al. Sequence Analysis of the Plasmid pGY1 Harbored in Salmonella enterica Serovar Paratyphi A. Bi-ochem Genet. 2009; 47: 191-197. doi: 10.1007/s10528-008-9216-0.
23. Liang WL, Zhao YB, Chen CX, Cui XY, Yu J, Xiao JF, et al. Pan-Genomic Analysis Provides Insights into the Genomic Variation and Evolution of Salmonella Paratyphi A. Plos One. 2012; 7. doi: 10.1371/journal.pone.0045346.
24. Kumar R, Sazawal S, Sinha A, Sood S, Bhan MK. Typhoid fever: contemporary issues as related to the disease in India. Round table conference series on water borne diseases. 12th ed. Ranbaxy Science Foundation, New Delhi, 1997; 2:31-36.
25. Nair S, Unnikrishnan M, Turner K, Parija SC, Churcher C, Wain J, et al. Molecular analysis of fluoroquinolone-resistant Salmonella Paratyphi A isolate, India. Emerg Infect Dis. 2006; 12: 489-491. doi:10.3201/eid1205.050560.
26. Kapil A, Sood S, Reddaiah VP, Das B, Seth P. Paratyphoid fever due to Salmonella enterica serotype Paratyphi A. Emerg Infect Dis. 1997; 3: 407. doi:10.3201/eid0303.970325.
27. Sood S, Kapil A, Dash N, Das BK, Goel V, Seth P. Paratyphoid fever in India: An emerging problem. Emerg Infect Dis. 1999; 5: 483-484.
28. Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect. 2006; 134: 961-966. doi: 10.1017/S0950268805005844.
29. Capoor MR, Nair D, Deb M, Aggarwal P. Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalo-sporins. J Med Microbiol. 2007; 56: 1131-1132. doi: 10.1099/jmm-0.47170-0.
30. Lathi N, Sudarsana J, Pushpa KK. Epidemic of Salmonella enterica serotype Paratyphi A in Calicut. Calicut Med J. 2004; 2: e2.
31. Gupta V, Kaur J, Chander J. An increase in enteric fever cases due to Salmonella Paratyphi A in & around Chandigarh. Indian J Med Res. 2009; 129: 95-98.
32. Rodrigues C, Shenai S, Mehta A. Enteric fever in Mumbai, India: The good news and the bad news. Clin Infect Dis. 2003; 36: 535. doi: 10.1086/367644.
33. Verma S, Thakur S, Kanga A, Singh G, Gupta P. Emerging Salmonella Para-typhi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla. Indian journal of medical microbiology. 2010; 28: 51-53. doi: 10.4103/0255-0857.58730.
34. Tankhiwale SS, Agrawal G, Jalgaonkar SV. An unusually high occurrence of Salmonella enterica serotype Paratyphi A in patients with enteric fever. Indian J Med Res. 2003; 117: 10-12.
35. Mendiratta DK, Deotale V, Thamke D, Narang R, Narang P. Enteric fever due to S. Paratyphi A-an emerging Problem. Indian J Med Microbiol. 2004; 22:196.
36. Joshi S, Amarnath SK. Fluoroquinolone resistance in Salmonella typhi and S. paratyphi An in Bangalore, India. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2007; 101: 308-310. doi:10.1016/j.trstmh.2006.05.009.
37. Indian Network for Surveillance of Antimicrobial Resistance Group. Antibio-gram of S. enterica serovar Typhi and S. enterica serovar Paratyphi A: a multi-centre study from India. WHO South-East Asia J Public Health. 2012; 1: 182-188.
38. Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid salmonellae in Rawalpindi, Pakistan. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 2005; 11: 1038-1044.
39. Khan MI, Soofi SB, Ochiai RL, Khan MJ, Sahito SM, Habib MA, et al. Epidemiology, clinical presentation, and patterns of drug resistance of Salmonella Typhi in Karachi, Pakistan. J Infect Dev Countr. 2012; 6: 704-714.
40. Murdoch DR, Woods CW, Zimmerman MD, Dull PM, Belbase RH, Keenan AJ, et al. The etiology of febrile illness in adults presenting to Patan hospital in Kathmandu, Nepal. The American journal of tropical medicine and hygiene. 2004; 70: 670-675.
41. Woods CW, Murdoch DR, Zimmerman MD, Glover WA, Basnyat B, Wolf L, et al. Emergence of Salmonella enterica serotype Paratyphi A as a major cause of enteric fever in Kathmandu, Nepal. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2006; 100: 1063-1067. doi: 10.1016/j.trstmh.2005.12.011.
42. Shirakawa T, Acharya B, Kinoshita S, Kumagai S, Gotoh A, Kawabata M. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003. Diagn Micr Infec Dis. 2006; 54: 299-303. doi: 10.1016/j.diagmicrobio.2005.10.016.
43. Maskey AP, Basnyat B, Thwaites GE, Campbell JI, Farrar JJ, Zimmerman MD. Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993-2003. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008; 102: 91-95. doi:10.1016/j.trstmh.2007.10.003.
44. Karkey A, Arjyal A, Anders KL, Boni MF, Dongol S, Koirala S, et al. The Burden and Characteristics of Enteric Fever at a Healthcare Facility in a Densely Populated Area of Kathmandu. Plos One. 2010; 5. doi: 10.1371/journal.pone.0013988.
45. Pokharel BM, Koirala J, Dahal RK, Mishra SK, Khadga PK, Tuladhar NR. Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives. Int J Infect Dis. 2006; 10: 434-438. doi: 10.1016/j.ijid.2006.07.001.
46. Naheed A, Ram PK, Brooks WA, Hossain MA, Parsons MB, Talukder KA, et al. Burden of typhoid and paratyphoid fever in a densely populated urban community, Dhaka, Bangladesh. Int J Infect Dis. 2010; 14 Suppl 3: e93-e99. doi:10.1016/j.ijid.2009.11.023.
47. Sheikh A, Charles RC, Rollins SM, Harris JB, Bhuiyan MS, Khanam F, et al. Analysis of Salmonella enterica serotype paratyphi A gene expression in the blood of bacteremic patients in Bangladesh. PLoS neglected tropical diseases. 2010; 4: e908. doi:10.1371/journal.pntd.0000908.
48. Yang J. Enteric Fever in South China: Guangxi Province. J Infect Dev Countr. 2008; 2: 283-288.
49. Wu WY, Wang H, Lu J, Wu JS, Chen MJ, Xu YC, et al. Genetic Diversity of Salmonella enterica serovar Typhi and Paratyphi in Shenzhen, China from 2002 through 2007. BMC Microbiol. 2010; 10.
50. Lam T, Mak D, Wong C. Review of notifiable diseases in Hong Kong, 2010. Public Health Epidemiology Bulletin, 2011; 20: 31-46.
51. Goh KT. An outbreak of paratyphoid A in Singapore: clinical and epidemio-logical studies. Southeast Asian J Trop Med Public Health. 1981; 12: 55-62.
52. Teoh YL, Goh KT, Neo KS, Yeo M. A nationwide outbreak of coconut-associated paratyphoid a fever in Singapore. Annals of the Academy of Medicine, Singapore. 1997; 26: 544-548.
53. Ty AU, Ang GY, Ang LW, James L, Goh KT. Changing Epidemiology of Enteric Fevers in Singapore. Ann Acad Med Singapore. 2010; 39: 889-896.
54. Jegathesan M. Salmonella serotypes isolated from man in Malaysia over the 10-year period 1973-1982. The Journal of hygiene. 1984; 92: 395-399.
55. Yasin RM, Jegathesan MM, Tiew CC. Salmonella serotypes isolated in Malaysia over the ten-year period 1983-1992. Asia-Pacific journal of public health/Asia-Pacific Academic Consortium for Public Health. 1996; 9: 1-5.
56. Commons RJ, McBryde E, Valcanis M, et al. Twenty-six years of enteric fever in Australia: an epidemiological analysis of antibiotic resistance. Med J Aust. 2012; 196: 332-336.
57. Blackstock SJ, Sheppeard VK, Paterson JM, Ralph AP. Typhoid and paratyphoid fever in Western Sydney Local Health District, NSW, January-June 2011. New South Wales public health bulletin. 2012; 23: 148-152. doi:10.1071/NB11041.
58. Threlfall EJ, Fisher IST, Berghold C, Gerner-Smidt P, Tschape H, Cormican M, et al. Trends in antimicrobial drug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolated in Europe, 1999-2001. Int J Antimicrob Ag. 2003; 22: 487-491. doi: 10.1016/S0924-8579(03)00262-0.
59. Health Protection Agency. Foreign travel-associated illness in England, Wales and Northern Ireland: 2007 report. London: Health Protection Agency. 2007.
60. Health Protection Agency. Migrant Health: Infectious diseases in non-UK born populations in the United Kingdom. An update to the baseline re-port-2011.London: Health Protection Agency. 2011.
61. Health Protection Agency. Enteric fever surveillance quarterly report (England, Wales and Northern Ireland) - first quarter 2012. HPR Weekly [serial online] 2012; 6 (19): enteric.
62. Health Protection Agency. Enteric fever surveillance quarterly report (England, Wales and Northern Ireland) - second quarter 2012. HPR Weekly [serial online] 2012; 6 (32): enteric.
63. Health Protection Agency. Enteric fever surveillance quarterly report (England, Wales and Northern Ireland) - third quarter 2012. HPR Weekly [serial online] 2012; 6 (45): enteric.
64. Health Protection Agency. Enteric fever surveillance quarterly report (England, Wales and Northern Ireland) - fourth quarter 2012. HPR Weekly [serial online] 2013; 7 (6): enteric.
65. Caumes E, Ehya N, Nguyen J, Bricaire F. Typhoid and paratyphoid fever: A 10-year retrospective study of 41 cases in a Parisian hospital. J Travel Med. 2001; 8: 293-297.
66. Walia M, Gaind R, Paul P, Mehta R, Aggarwal P, Kalaivani M. Age-related clinical and microbiological characteristics of enteric fever in India. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2006; 100: 942-948. doi: 10.1016/j.trstmh.2006.02.015.
67. Khuribulos N. Enteric Fevers in Children - the Importance of Age in the Varying Clinical Picture. Clin Pediatr. 1981; 20: 448-452. doi: 10.1177/000992288102000704.
68. Joshi S, Wattal C, Sharma A, Prasad KJ. Mixed Salmonella infection - a case report. Indian journal of medical microbiology. 2002; 20: 113-114.
69. Humphries RM, Yeganeh N, Ward KW, Lewinski MA, Ching N. Enteric fever in a 6-year-old traveler caused by Salmonella enterica serotypes Typhi and Par-atyphi A: laboratory detection strategies and treatment options. Journal of clinical microbiology. 2011; 49: 452-454. doi:10.1128/JCM.01316-10.
70. Walker RA, Skinner JA, Ward LR, Threlfall EJ. LightCycler gyrA mutation assay (GAMA) identifies heterogeneity in GyrA in Salmonella enterica sero-types Typhi and Paratyphi A with decreased susceptibility to ciprofloxacin. Int J Antimicrob Agents. 2003; 22: 622-625.
71. Chandel DS, Chaudhry R, Dhawan B, Pandey A, Dey AB. Drug-resistant Salmonella enterica serotype paratyphi A in India. Emerg Infect Dis. 2000; 6: 420-421. doi:10.3201/eid0604.000420.
72. Bhattacharya SS, Das U, Choudhury BK. Occurrence & antibiogram of Salmonella Typhi & S. Paratyphi A isolated from Rourkela, Orissa. Indian J Med Res. 2011; 133: 431-433.
73. Dimitrov T, Udo EE, Albaksami O, Al-Shehab S, Kilani A, Shehab M, et al. Clinical and microbiological investigations of typhoid fever in an infectious disease hospital in Kuwait. J Med Microbiol. 2007; 56: 538-544. doi:10.1099/jmm.0.46814-0.
74. Zaki SA, Karande S. Multidrug-resistant typhoid fever: a review. J Infect Dev Ctries. 2011; 5: 324-337.
75. Parry CM, Ho VA, Phuong le T, Bay PV, Lanh MN, Tung le T, et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxa-cin-azithromycin combination for treatment of multidrug-resistant and na-lidixic acid-resistant typhoid fever. Antimicrobial agents and chemotherapy. 2007; 51: 819-825. doi:10.1128/AAC.00447-06.
76. Crump JA, Mintz ED. Global Trends in Typhoid and Paratyphoid Fever. Clin Infect Dis. 2010; 50: 241-246. doi: 10.1086/6495.
77. Dolecek C, Tran TP, Nguyen NR, Le TP, Ha V, Phung QT, et al. A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. Plos One. 2008; 3: e2188. doi:10.1371/journal.pone.0002188.
78. Trivedi NA, Shah PC. A meta-analysis comparing the safety and efficacy of azithromycin over the alternate drugs used for treatment of uncomplicated enteric fever. Journal of postgraduate medicine. 2012; 58: 112-118. doi: 10.4103/0022-3859.97172.
79. Aggarwal A, Ghosh A, Gomber S, Mitra M, Parikh AO. Efficacy and safety of azithromycin for uncomplicated typhoid fever: an open label non-comparative study. Indian pediatrics. 2011; 48: 553-556.
80. Sjolund-Karlsson M, Joyce K, Blickenstaff K, Ball T, Haro J, Medalla FM, et al. Antimicrobial susceptibility to azithromycin among Salmonella enterica isolates from the United States. Antimicrobial agents and chemotherapy. 2011; 55: 3985-3989. doi:10.1128/AAC.00590-11.
81. Molloy A, Nair S, Cooke FJ, Wain J, Farrington M, Lehner PJ, et al. First report of Salmonella enterica serotype paratyphi A azithromycin resistance leading to treatment failure. Journal of clinical microbiology. 2010; 48: 4655-4657. doi:10.1128/JCM.00648-10.
82. Pancharoen C, Thisyakorn C, Thisyakorn U. Endocarditis and pericarditis caused by Salmonella paratyphi A: two case reports and review of the literature. The Southeast Asian journal of tropical medicine and public health. 2002; 33: 161-163.
83. Sanchez-Guerrero J, Alarcon-Segovia D. Salmonella pericarditis with tam-ponade in systemic lupus erythematosus. British journal of rheumatology. 1990; 29: 69-71.
84. Gupta S, Singh B, Kapoor H, Minocha SK, Jain AK. Ventricular septal defect with endocarditis caused by Salmonella Paratyphi A. Trop Doct. 1994; 24: 40.
85. Johnson DH, Rosenthal A, Nadas AS. Bacterial endocarditis in children under 2 years of age. American journal of diseases of children. 1975; 129: 183-186.
86. Chaudhry R, Chandel DS, Pandey A, Dhawan B, Gulati V, Sood R. Utility of PCR in diagnosing complicated cases of unusual clinical manifestations of Salmonella enterica var. Paratyphi A. The American journal of medicine. 2005; 118: 799-800. doi:10.1016/j.amjmed.2004.12.030.
87. Hu L and Kopecko DJ. Salmonella Typhi and Paratyphi. In Sussman M, ed. Molecular Medical Microbiology 2. Carlifornia: Academic Press; 2002: 1365-1391.
88. Kudalkar D, Thermidor M, Cunha BA. Salmonella paratyphi A enteric fever mimicking viral meningitis. Heart & lung: the journal of critical care. 2004; 33: 414-416.
89. Jeans AR, McKendrick MW. Salmonella Paratyphi A liver abscess--secondary infection of an amoebic liver abscess? Travel medicine and infectious disease. 2007; 5: 144-146. doi:10.1016/j.tmaid.2006.01.004.
90. Wain J, Diep TS, Ho VA, Walsh AM, Nguyen TT, Parry CM, et al. Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. Journal of clinical microbiology. 1998; 36: 1683-1687.
91. Ekpo P, Sarasombath S. Expression of Salmonella Paratyphi B and Salmonella Paratyphi C flagellin/glutathione S-transferase fusion protein. Sotheast Asian J Trop Med Publ Health. 1999; 26 (Suppl2): S192-S194.
92. Parry CM, Hoa NTT, Diep TS, Wain J, Chinh NT, Vinh H, et al. Value of a single-tube Widal test in diagnosis of typhoid fever in Vietnam. Journal of clinical microbiology. 1999; 37: 2882-2886.
93. Willke A, Ergonul O, Bayar B. Widal test in diagnosis of typhoid fever in Turkey. Clinical and diagnostic laboratory immunology. 2002; 9: 938-941.
94. Tam FCH, Wang ML, Dong BQ, Leung DTM, Ma CH, Lim PL. New rapid test for paratyphoid a fever: usefulness, cross-detection, and solution. Diagn Micr Infec Dis. 2008; 62: 142-150. doi: 10.1016/j.diagmicrobio.2008.07.002.
95. Tracz DM, Tabor H, Jerome M, Ng LK, Gilmour MW. Genetic determinants and polymorphisms specific for human-adapted serovars of Salmonella enterica that cause enteric fever. Journal of clinical microbiology. 2006; 44: 2007-2018. doi: 10.1128/Jcm.02630-05.
96. Nissen MD, Sloots TP. Rapid diagnosis in pediatric infectious diseases: the past, the present and the future. Pediatr Infect Dis J. 2002; 21: 605-612; discussion 13-4.
97. Hirose K, Itoh K, Nakajima H, Kurazono T, Yamaguchi M, Moriya K, et al. Selective amplification of tyv (rfbE), prt (rfbS), viaB, and fliC genes by multiplex PCR for identification of Salmonella enterica serovars Typhi and Paratyphi A. Journal of clinical microbiology. 2002; 40: 633-636.
98. Ou HY, Teh CSJ, Thong KL, Ahmad N, Deng ZX, Barer MR, et al. Translational genomics to develop a Salmonella enterica serovar Paratyphi A multiplex polymerase chain reaction assay. J Mol Diagn. 2007; 9: 624-630. doi: 10.2353/jmoldx.2007.070064.
99. Teh CSJ, Chua KH, Puthucheary SD, Thong KL. Further evaluation of a multiplex PCR for differentiation of Salmonella Paratyphi A from other Salmonel-lae. Jpn J Infect Dis. 2008; 61: 313-314.
100. Nga TV, Karkey A, Dongol S, Thuy HN, Dunstan S, Holt K, et al. The sensitivity of real-time PCR amplification targeting invasive Salmonella serovars in biological specimens. Bmc Infect Dis. 2010; 10: 125. doi:10.1186/1471-2334-10-125.
101. Arya SC, Sharma KB. Urgent need for effective vaccine against Salmonella paratyphi A, B and C. Vaccine. 1995; 13: 1727-1728. doi: 10.1016/0264-410x(96)81276-X.
102. Konadu EY, Lin FYC, Ho VA, Thuy NTT, Bay PV, Thanh TC, et al. Phase 1 and phase 2 studies of Salmonella enterica serovar Paratyphi A O-specific polysac-charide-tetanus toroid conjugates in adults, teenagers, and 2-to 4-year-old children in Vietnam. Infect Immun. 2000; 68: 1529-1534. doi: 10.1128/Iai.68.3.1529-1534.2000.
103. Roland KL, Tinge SA, Kochi SK, Thomas LJ, Killeen KP. Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidates. Vaccine. 2010; 28: 3679-3687. doi:10.1016/j.vaccine.2010.03.019.
104. Gat O, Galen JE, Tennant S, Simon R, Blackwelder WC, Silverman DJ, et al. Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines. PLoS neglected tropical diseases. 2011; 5: e1373. doi:10.1371/journal.pntd.0001373.
105. Micoli F, Rondini S, Gavini M, Lanzilao L, Medaglini D, Saul A, et al. O:2-CRM(197) conjugates against Salmonella Paratyphi A. Plos One. 2012; 7: e47039. doi:10.1371/journal.pone.0047039.